Obsessive-compulsive disorder (OCD) Investigational Medication

Brief description of study

The Center for the Treatment and Study of Anxiety is offering an investigational medication for people who have obsessive-compulsive disorder (OCD) and are currently taking an SRI medication for their OCD but still have unwanted symptoms.

Detailed description of study

The Center for the Treatment and Study of Anxiety is offering an investigational medication for people who have obsessive-compulsive disorder (OCD) and are currently taking one of the below medications for their OCD but still have unwanted symptoms. 



Are you taking one of the following medications for obsessive-compulsive disorder?


    • Clomipramine (Anafranil)
    • Fluoxetine (Prozac)
    • Fluvoxamine (Luvox)
    • Sertraline (Zoloft)
    • Paroxetine (Paxil)
    • Citalopram (Celexa)
    • Escitalopram (Lexapro)



Eligible participants remain on a stable dose of their OCD medication in the first part of the study, and will receive an investigational medication or a placebo as additional treatment for 10 weeks. Individuals who do not improve will be referred elsewhere to receive appropriate clinical treatment.

 

Men and women ages 18-75 with OCD who are currently taking an SRI medication (Prozac, Zoloft, Paxil, Luvox, Celexa, Lexapro or Anafranil) may be eligible to participate in this study.  There is no cost for this study. Participants may be compensated to $525 for their participation.


Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    OCD,Obessive Compulsive Disorder
  • Age: Between 18 Years - 75 Years
  • Gender: All
Updated on 26 Jul 2022. Study ID: 828488

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center